3696:HKG
Insilico Medicine Cayman TopCo
HK$50.50
arrow_downward
-6.31%(-3.40) 1D
Sep 11, 4:08:54 PM GMT+8 · HKD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 3696...
Open
HK$53.35
High
HK$53.35
Low
HK$49.00
Mkt. cap
29.41B
Avg. vol.
0.00
Volume
24.30M
52-wk high
HK$80.90
52-wk low
HK$29.98
EPS
-HK$4.20
Shares outstanding
557.42M
No. of employees
333
Open
HK$53.35
High
HK$53.35
Low
HK$49.00
Mkt. cap
29.41B
Avg. vol.
0.00
Volume
24.30M
52-wk high
HK$80.90
52-wk low
HK$29.98
EPS
-HK$4.20
Shares outstanding
557.42M
No. of employees
333
News stories
From web sources and news partners
Profile
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company applies genomics, big data analysis, and deep learning for in silico drug discovery. Wikipedia
About Insilico Medicine Cayman TopCo
CEOFeng Ren | Alex Zhavoronkov
Employees333
Founded2014
Headquarters-
SectorHealth care
Websiteinsilico.com